STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

ENANTA PHARMACEUTICALS INC

Filed

November 26, 2025

Period of Report

November 25, 2025

Accession Number

0002064832-25-000030